• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Is it time for a paradigm shift in treatment guidelines for chronic hepatitis B?

作者信息

Johannessen Asgeir

机构信息

Department of Infectious Diseases, Vestfold Hospital, Tønsberg 3103, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

出版信息

Lancet Gastroenterol Hepatol. 2023 Sep;8(9):784. doi: 10.1016/S2468-1253(23)00236-4. Epub 2023 Jul 27.

DOI:10.1016/S2468-1253(23)00236-4
PMID:37517416
Abstract
摘要

相似文献

1
Is it time for a paradigm shift in treatment guidelines for chronic hepatitis B?
Lancet Gastroenterol Hepatol. 2023 Sep;8(9):784. doi: 10.1016/S2468-1253(23)00236-4. Epub 2023 Jul 27.
2
Oral antiviral therapy reduces the risk of hepatocellular carcinoma in persons with chronic hepatitis B infection: combining evidence and common sense.
Hepatol Int. 2016 Mar;10(2):239-41. doi: 10.1007/s12072-016-9714-9. Epub 2016 Feb 23.
3
Universal hepatitis B vaccination: The only way to eliminate hepatocellular carcinoma?
J Hepatol. 2015 Dec;63(6):1303-5. doi: 10.1016/j.jhep.2015.10.001. Epub 2015 Oct 9.
4
Nucleos(t)ide analogs reduce the risk of hepatitis B-associated hepatocellular carcinoma: A can't miss proposition?核苷（酸）类似物可降低乙型肝炎相关肝细胞癌的风险：一个不容错过的提议？
Hepatology. 2016 May;63(5):1415-7. doi: 10.1002/hep.28404. Epub 2016 Feb 19.
5
Can tertiary prevention of hepatocellular carcinoma be achieved by nucleos(t)ide analogs therapy of hepatitis B?乙肝的核苷（酸）类似物疗法能否实现肝细胞癌的三级预防？
J Gastroenterol Hepatol. 2011 Dec;26(12):1699-701. doi: 10.1111/j.1440-1746.2011.06931.x.
6
Antiviral therapy after curative treatment of hepatocellular carcinoma in patients with chronic hepatitis B infection: Is tenofovir or entecavir preferred?慢性乙型肝炎感染患者肝细胞癌根治性治疗后的抗病毒治疗：替诺福韦还是恩替卡韦更优？
Eur J Intern Med. 2021 Jul;89:27-29. doi: 10.1016/j.ejim.2021.05.003. Epub 2021 May 20.
7
[Low-level viremia-induced liver fibrosis and hepatocellular carcinoma in chronic hepatitis B].[慢性乙型肝炎中低水平病毒血症诱导的肝纤维化和肝细胞癌]
Zhonghua Gan Zang Bing Za Zhi. 2021 Dec 20;29(12):1144-1146. doi: 10.3760/cma.j.cn501113-20211124-00577.
8
Nucleos(t)ide analogue therapy for HBV-related HCC after hepatic resection: clinical benefits and unanswered questions.肝切除术后核苷（酸）类似物治疗HBV相关肝癌：临床益处与未解决的问题
Tumour Biol. 2014 Dec;35(12):12779-84. doi: 10.1007/s13277-014-2881-1. Epub 2014 Nov 28.
9
Tenofovir versus entecavir in prevention of hepatocellular carcinoma and mortality in patients with chronic hepatitis B.替诺福韦与恩替卡韦预防慢性乙型肝炎患者肝细胞癌及死亡的比较
Gut. 2020 Nov;69(11):2054-2056. doi: 10.1136/gutjnl-2019-320554. Epub 2020 Feb 10.
10
Letter: tenofovir may be superior to entecavir for treatment-naïve chronic hepatitis B patients.信函：对于初治慢性乙型肝炎患者，替诺福韦可能优于恩替卡韦。
Aliment Pharmacol Ther. 2021 May;53(9):1048-1049. doi: 10.1111/apt.16323.

引用本文的文献

1
Barriers to longitudinal follow-up for hepatitis B treatment in rural Sierra Leone: A mixed methods study of retention in care.塞拉利昂农村地区乙肝治疗长期随访的障碍：一项关于治疗依从性的混合方法研究
Clin Liver Dis (Hoboken). 2024 May 31;23(1):e0225. doi: 10.1097/CLD.0000000000000225. eCollection 2024 Jan-Jun.